🔎 Trials Near Me

Beranda › Kanker Kolon › Massachusetts › Boston

Uji klinis Kanker Kolon di Boston, MA

22 studi untuk Kanker Kolon mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Distance-Based Exercise to Preserve Function and Prevent Disability

Menerima peserta
  • Dana-Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

A Study of PHN-012 in Patients With Advanced Solid Tumors

Menerima pesertaFase 1
  • PHN-012-001 Site, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07127874

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Menerima pesertaFase 3
  • Brigham and Women's Hospital (BWH), Boston
  • Dana-Farber Cancer Institute (DFCI), Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Menerima pesertaFase 1/2
  • Dana Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Menerima pesertaFase 1/2
  • Massachusetts General Hospital - Main Campus, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07629960

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Menerima pesertaFase 3
  • Massachusetts General Hospital, Boston
  • Oncura Health, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07284849

Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial

Menerima peserta
  • Dana Farber Cancer Institute, Boston
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06202183

Resilience and Equity in Aging, Cancer, and Health (REACH)

Menerima peserta
  • Dana-Farber Cancer Institute, Boston
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT04674267

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Menerima peserta
  • Massachusetts General Hospital Cancer Center, Boston
Usia 45 hingga 70 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Menerima pesertaFase 2/3
  • Tufts Medical Center, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05174169

Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

Menerima pesertaStudi observasional
  • Dana-Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT07675967

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Menerima pesertaFase 1
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07458347

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Menerima pesertaFase 1
  • Research Site, Boston
  • Research Site, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Menerima pesertaFase 1
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT06040541

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Menerima pesertaFase 1/2
  • Massachusetts General Hospital,, Boston
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 27 Mei 2026 · NCT03093116

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Menerima pesertaFase 1/2
  • Dana Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Menerima pesertaFase awal 1
  • Dana-Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT02172651

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Menerima pesertaStudi observasional
  • Dana Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT00843375

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Massachusetts General Hospital, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT06239194

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

Menerima peserta
  • Dana-Farber Cancer Institute, Boston
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT05773144

Building Connections

Menerima peserta
  • Disparities Research Unit, Massachusetts General Hospital, Boston
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 18 Nov 2025 · NCT07091032

Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study

Menerima pesertaSukarelawan sehat diterima
  • Codman Square Health Center, Boston
  • East Boston Neighborhood Health Center, East Boston · 2 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT05524428

Uji klinis Kanker Kolon di kota lain

Studi lain di Boston

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.